Variant report
Variant | esv3377852 |
---|---|
Chromosome Location | chr3:25016997-25034543 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182817074 | chr3:25022601-25022602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556617457 | chr3:25022660-25022661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186770545 | chr3:25022664-25022665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372766717 | chr3:25022669-25022670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs543840364 | chr3:25022685-25022686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563817330 | chr3:25022762-25022763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542106066 | chr3:25022763-25022764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540031547 | chr3:25022766-25022767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375167585 | chr3:25022818-25022819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560306562 | chr3:25022829-25022830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573375586 | chr3:25022852-25022853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4519669 | chr3:25022866-25022867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529130870 | chr3:25022946-25022947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549282632 | chr3:25022961-25022962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555924710 | chr3:25022994-25022995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562703582 | chr3:25022996-25022997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531719579 | chr3:25023019-25023020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191528145 | chr3:25023038-25023039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs111900689 | chr3:25023042-25023043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539011400 | chr3:25023077-25023078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184840283 | chr3:25023081-25023082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs545546404 | chr3:25023088-25023089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564480337 | chr3:25023092-25023093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560400547 | chr3:25023096-25023097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs148687780 | chr3:25023097-25023098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116491578 | chr3:25023127-25023128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4511858 | chr3:25023137-25023138 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs536511817 | chr3:25023143-25023144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs4075414 | chr3:25023150-25023151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576357721 | chr3:25023157-25023158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs537446022 | chr3:25023167-25023168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4254625 | chr3:25023212-25023213 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs116264252 | chr3:25023221-25023222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539944745 | chr3:25023241-25023242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560063162 | chr3:25023304-25023305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34587243 | chr3:25023335-25023336 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs542488866 | chr3:25023345-25023346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562777136 | chr3:25023360-25023361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531681965 | chr3:25023361-25023362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144958772 | chr3:25023366-25023367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4075413 | chr3:25023381-25023382 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs76024928 | chr3:25023410-25023411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547890565 | chr3:25023417-25023418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567689488 | chr3:25023502-25023503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565930601 | chr3:25023530-25023531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530294264 | chr3:25023543-25023544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs117756391 | chr3:25023560-25023561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190242428 | chr3:25023605-25023606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs193258401 | chr3:25023630-25023631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs367874433 | chr3:25023632-25023633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:25022600-25025200 | Enhancers | Fetal Muscle Leg | muscle |
2 | chr3:25022800-25023200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr3:25022800-25023800 | Enhancers | Fetal Muscle Trunk | muscle |
4 | chr3:25023000-25023800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
5 | chr3:25023000-25024000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
6 | chr3:25023200-25024400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
7 | chr3:25023400-25024400 | Enhancers | Fetal Stomach | stomach |
8 | chr3:25023600-25024800 | Enhancers | Psoas Muscle | Psoas |
9 | chr3:25023800-25024200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr3:25023800-25024200 | Enhancers | Fetal Lung | lung |
11 | chr3:25025200-25027200 | Weak transcription | Fetal Muscle Leg | muscle |
12 | chr3:25027200-25027400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr3:25027200-25027400 | Enhancers | Fetal Muscle Leg | muscle |